Journal
Journal of experimental medicine
Publication Date
7-2-2018
Volume
215
Issue
7
First Page
1823
Last Page
1838
Document Type
Open Access Publication
DOI
10.1084/jem.20171704
Rights and Permissions
Jeremy P. Huynh, Chih-Chung Lin, Jacqueline M. Kimmey, Nicholas N. Jarjour, Elizabeth A. Schwarzkopf, Tara R. Bradstreet, Irina Shchukina, Oleg Shpynov, Casey T. Weaver, Reshma Taneja, Maxim N. Artyomov, Brian T. Edelson, Christina L. Stallings; Bhlhe40 is an essential repressor of IL-10 during Mycobacterium tuberculosis infection. J Exp Med 2 July 2018; 215 (7): 1823–1838. @2018 Huynh et al. Originally published in Journal of Experimental Medicine. doi: https://doi.org/10.1084/jem.20171704.
Recommended Citation
Huynh, Jeremy P; Lin, Chih-Chung; Kimmey, Jacqueline M; Jarjour, Nicholas N; Schwarzkopf, Elizabeth A; Bradstreet, Tara R; Shchukina, Irina; Shpynov, Oleg; Weaver, Casey T; Taneja, Reshma; Artyomov, Maxim N; Edelson, Brian T; and Stallings, Christina L, "Bhlhe40 is an essential repressor of IL-10 during Mycobacterium tuberculosis infection." Journal of experimental medicine. 215, 7. 1823 - 1838. (2018).
https://digitalcommons.wustl.edu/oa_3/59
Table S1. Bhlhe40 binding sites in GM-CSF-cultured cells; Table S2. Bhlhe40 binding sites in TH1-polarized T cells
